ID   DGKQ_RAT                Reviewed;         937 AA.
AC   D3ZEY4;
DT   07-OCT-2020, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   02-OCT-2024, entry version 113.
DE   RecName: Full=Diacylglycerol kinase theta {ECO:0000305};
DE            Short=DAG kinase theta;
DE            Short=DGKtheta {ECO:0000303|PubMed:9099683};
DE            EC=2.7.1.107 {ECO:0000269|PubMed:15337525};
DE            EC=2.7.1.93 {ECO:0000250|UniProtKB:P52824};
GN   Name=Dgkq {ECO:0000312|RGD:2320722};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=9099683; DOI=10.1074/jbc.272.16.10422;
RA   Houssa B., Schaap D., van der Wal J., Goto K., Kondo H., Yamakawa A.,
RA   Shibata M., Takenawa T., van Blitterswijk W.J.;
RT   "Cloning of a novel human diacylglycerol kinase (DGKtheta) containing three
RT   cysteine-rich domains, a proline-rich region, and a pleckstrin homology
RT   domain with an overlapping Ras-associating domain.";
RL   J. Biol. Chem. 272:10422-10428(1997).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, PATHWAY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15337525; DOI=10.1016/j.cellsig.2004.03.018;
RA   Tabellini G., Billi A.M., Fala F., Cappellini A., Evagelisti C.,
RA   Manzoli L., Cocco L., Martelli A.M.;
RT   "Nuclear diacylglycerol kinase-theta is activated in response to nerve
RT   growth factor stimulation of PC12 cells.";
RL   Cell. Signal. 16:1263-1271(2004).
CC   -!- FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into
CC       phosphatidic acid/phosphatidate/PA and regulates the respective levels
CC       of these two bioactive lipids (PubMed:15337525). Thereby, acts as a
CC       central switch between the signaling pathways activated by these second
CC       messengers with different cellular targets and opposite effects in
CC       numerous biological processes (PubMed:15337525). Within the
CC       adrenocorticotropic hormone signaling pathway, produces phosphatidic
CC       acid which in turn activates NR5A1 and subsequent steroidogenic gene
CC       transcription (By similarity). Also functions downstream of the nerve
CC       growth factor signaling pathway being specifically activated in the
CC       nucleus by the growth factor (PubMed:15337525). Through its
CC       diacylglycerol activity also regulates synaptic vesicle endocytosis (By
CC       similarity). {ECO:0000250|UniProtKB:P52824,
CC       ECO:0000269|PubMed:15337525}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + ATP = a 1,2-diacyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:10272, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:30616, ChEBI:CHEBI:58608,
CC         ChEBI:CHEBI:456216; EC=2.7.1.107;
CC         Evidence={ECO:0000269|PubMed:15337525};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10273;
CC         Evidence={ECO:0000305|PubMed:15337525};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-sn-glycerol + ATP = 1-O-alkyl-sn-glycero-3-phosphate
CC         + ADP + H(+); Xref=Rhea:RHEA:16937, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15850, ChEBI:CHEBI:30616, ChEBI:CHEBI:58014,
CC         ChEBI:CHEBI:456216; EC=2.7.1.93;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16938;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-2-acyl-sn-glycerol + ATP = 1-O-alkyl-2-acyl-sn-
CC         glycero-3-phosphate + ADP + H(+); Xref=Rhea:RHEA:44072,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:52595,
CC         ChEBI:CHEBI:73332, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44073;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + ATP = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40327, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:74546, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15337525};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40328;
CC         Evidence={ECO:0000305|PubMed:15337525};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-sn-glycerol + ATP = 1-O-hexadecyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:41672, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:34115, ChEBI:CHEBI:77580,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P52824};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41673;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-2-acetyl-sn-glycerol + ATP = 1-O-hexadecyl-2-
CC         acetyl-sn-glycero-3-phosphate + ADP + H(+); Xref=Rhea:RHEA:41676,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:75936,
CC         ChEBI:CHEBI:78385, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41677;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40323, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:75728, ChEBI:CHEBI:77091,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P52824};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40324;
CC         Evidence={ECO:0000250|UniProtKB:P52824};
CC   -!- ACTIVITY REGULATION: Activated by phosphatidylserine.
CC       {ECO:0000269|PubMed:15337525}.
CC   -!- PATHWAY: Lipid metabolism; glycerolipid metabolism.
CC       {ECO:0000269|PubMed:15337525}.
CC   -!- SUBUNIT: Interacts with RHOA (constitutively activated, GTP-bound); the
CC       interaction inhibits DGKQ. Interacts with PRKCE. Interacts with PRKCH.
CC       Interacts with PLCB1. Interacts with NR5A1; the interaction requires
CC       both LXXLL motifs in DGKQ and is required for full phosphatidic acid-
CC       mediated activation of NR5A1. {ECO:0000250|UniProtKB:P52824}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P52824}.
CC       Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q6P5E8}. Cell membrane
CC       {ECO:0000250|UniProtKB:P52824}. Synapse {ECO:0000250|UniProtKB:Q6P5E8}.
CC       Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:P52824}. Nucleus
CC       {ECO:0000269|PubMed:15337525}. Nucleus speckle
CC       {ECO:0000269|PubMed:15337525}. Nucleus matrix
CC       {ECO:0000269|PubMed:15337525}. Note=Translocates to the plasma membrane
CC       in response to steroid hormone receptor stimulation. Translocation to
CC       the plasma membrane is dependent on G-protein coupled receptor
CC       stimulation and subsequent activation of PRKCE and probably PRKCH.
CC       Translocates to the nucleus in response to thrombin stimulation (By
CC       similarity). Association with the nuclear matrix is regulated by nerve
CC       growth factor (PubMed:15337525). {ECO:0000250|UniProtKB:P52824,
CC       ECO:0000269|PubMed:15337525}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in the
CC       brain and, to a lesser extent, in the small intestine, duodenum, and
CC       liver (PubMed:9099683). In brain, expressed in gray matter
CC       (PubMed:9099683). Expression is most intense in the cerebellar cortex
CC       and hippocampus, while moderate expression is seen in the olfactory
CC       bulb neuronal layers and brain stem nuclei (PubMed:9099683). In the
CC       cerebellar cortex, equally expressed in both the Purkinje cell somata
CC       and the granule cells (PubMed:9099683). {ECO:0000269|PubMed:9099683}.
CC   -!- DOMAIN: The L-X-X-L-L repeats are both required for binding and
CC       phosphatidic acid-mediated activation of the nuclear receptor NR5A1.
CC       {ECO:0000250|UniProtKB:P52824}.
CC   -!- PTM: Phosphorylated by PRKCE and PRKCH in vitro.
CC       {ECO:0000250|UniProtKB:P52824}.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC117047; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH474079; EDL84024.1; -; Genomic_DNA.
DR   RefSeq; NP_001185733.1; NM_001198804.1.
DR   AlphaFoldDB; D3ZEY4; -.
DR   SMR; D3ZEY4; -.
DR   IntAct; D3ZEY4; 1.
DR   STRING; 10116.ENSRNOP00000036466; -.
DR   iPTMnet; D3ZEY4; -.
DR   PhosphoSitePlus; D3ZEY4; -.
DR   PaxDb; 10116-ENSRNOP00000036466; -.
DR   PeptideAtlas; D3ZEY4; -.
DR   Ensembl; ENSRNOT00000032056.6; ENSRNOP00000036466.4; ENSRNOG00000024112.6.
DR   Ensembl; ENSRNOT00055046265; ENSRNOP00055037979; ENSRNOG00055026787.
DR   Ensembl; ENSRNOT00060019100; ENSRNOP00060014921; ENSRNOG00060011295.
DR   Ensembl; ENSRNOT00065019866; ENSRNOP00065015224; ENSRNOG00065012225.
DR   GeneID; 100361138; -.
DR   KEGG; rno:100361138; -.
DR   UCSC; RGD:2320722; rat.
DR   AGR; RGD:2320722; -.
DR   CTD; 1609; -.
DR   RGD; 2320722; Dgkq.
DR   eggNOG; KOG1169; Eukaryota.
DR   GeneTree; ENSGT00940000159492; -.
DR   HOGENOM; CLU_003770_0_0_1; -.
DR   InParanoid; D3ZEY4; -.
DR   OMA; GFHHARE; -.
DR   OrthoDB; 4642163at2759; -.
DR   PhylomeDB; D3ZEY4; -.
DR   TreeFam; TF312817; -.
DR   Reactome; R-RNO-114508; Effects of PIP2 hydrolysis.
DR   UniPathway; UPA00230; -.
DR   PRO; PR:D3ZEY4; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Proteomes; UP000234681; Chromosome 14.
DR   Bgee; ENSRNOG00000024112; Expressed in jejunum and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005768; C:endosome; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0016363; C:nuclear matrix; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098794; C:postsynapse; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0012506; C:vesicle membrane; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004143; F:ATP-dependent diacylglycerol kinase activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0019900; F:kinase binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043274; F:phospholipase binding; ISO:RGD.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; ISO:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISO:RGD.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; ISS:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0046486; P:glycerolipid metabolic process; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0046834; P:lipid phosphorylation; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0010801; P:negative regulation of peptidyl-threonine phosphorylation; ISO:RGD.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0070528; P:protein kinase C signaling; ISO:RGD.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0090181; P:regulation of cholesterol metabolic process; ISO:RGD.
DR   GO; GO:2000064; P:regulation of cortisol biosynthetic process; ISO:RGD.
DR   GO; GO:0008277; P:regulation of G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; ISO:RGD.
DR   GO; GO:2000182; P:regulation of progesterone biosynthetic process; ISO:RGD.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; ISO:RGD.
DR   GO; GO:1903432; P:regulation of TORC1 signaling; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0033198; P:response to ATP; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; ISO:RGD.
DR   GO; GO:0070493; P:thrombin-activated receptor signaling pathway; ISO:RGD.
DR   CDD; cd20803; C1_DGKtheta_typeV_rpt1; 1.
DR   CDD; cd20804; C1_DGKtheta_typeV_rpt2; 1.
DR   CDD; cd20854; C1_DGKtheta_typeV_rpt3; 1.
DR   CDD; cd17111; RA1_DAGK-theta; 1.
DR   CDD; cd01783; RA2_DAGK-theta; 1.
DR   Gene3D; 2.60.200.40; -; 1.
DR   Gene3D; 3.30.60.20; -; 2.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR037607; DGK.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000159; RA_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR11255; DIACYLGLYCEROL KINASE; 1.
DR   PANTHER; PTHR11255:SF54; DIACYLGLYCEROL KINASE THETA; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   Pfam; PF00788; RA; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 3.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SMART; SM00314; RA; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 3.
DR   SUPFAM; SSF111331; NAD kinase/diacylglycerol kinase-like; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 2.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS50200; RA; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 3.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 3.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Cytoplasm; Cytoskeleton; Kinase;
KW   Lipid metabolism; Membrane; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Synapse; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..937
FT                   /note="Diacylglycerol kinase theta"
FT                   /id="PRO_0000450756"
FT   DOMAIN          390..489
FT                   /note="Ras-associating"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00166"
FT   DOMAIN          579..716
FT                   /note="DAGKc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   ZN_FING         54..102
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         115..162
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         177..228
FT                   /note="Phorbol-ester/DAG-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          359..378
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          911..937
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           550..554
FT                   /note="LXXLL motif 1"
FT                   /evidence="ECO:0000250|UniProtKB:P52824"
FT   MOTIF           569..573
FT                   /note="LXXLL motif 2"
FT                   /evidence="ECO:0000250|UniProtKB:P52824"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P5E8"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P5E8"
SQ   SEQUENCE   937 AA;  102545 MW;  9E0EAEAFD5A99716 CRC64;
     MATAAESGAR TWPGSGSPRL GSPAGSPVLG ISGRARPGSG PERTGRAIGS VAPGHSFRKV
     TLTKPTFCHL CSDFIWGLAG FLCDVCNFMS HEKCLKQVKT PCTSIAPSLV RVPVAHCFGS
     LGLYKRKFCV VCRKSLEVPA FRCEVCELHV HPDCVPFACS DCRQCHQDGQ HDYDTYHHHW
     REGNLPSGAR CEVCRKTCGS SDVLAGVRCE WCGVQAHSVC STALTPECTF GRLRSMVLPP
     SCVRLLSRNF SKMHCFRIPE TMVLELGDGD DGLDGSAAVG TGREVSAATE STKQTLKIFD
     GNDSMRKNQF RLVTVSRLAR NEEVMEAALR AYYINEDPKD FQLQALPLTL LSGNAQALGK
     AGTTEEETSK DSGPGDSVPE AWVIRSLPRT QEILKIYPDW LKVGVAYVSI RVNSQSTARS
     VVQEVLPLFG RQVEDQERFQ LIEVLMSSRQ VQRTVLVDEE PLLDRLRDIR QTSVRQASQT
     RFYVAEARAV TPHVSLFVGG LPPGLSPQDY SNLLHEAMAT KAAVVSVSHV YSLQGAVVLD
     VTCFAEAERL YMLARDTAVH GRPLTALVLP DVLHTKLPPD CCPLLVFVNP KSGGLKGREL
     LCSFRKLLNP HQVFELTNGG PLPGFHLFSQ VPCFRVLVCG GDGTVGWVLA ALEETRRHLA
     CPEPSVAILP LGTGNDLGRV LRWGAGYSGE DPFSVLVSVD EADAVLMDRW TILLDAHEID
     STENNVVETE PPKIVQMNNY CGIGIDAELS LDFHQAREEE PGKFTSRFHN KGVYVRVGLQ
     KISHSRSLHK EIRLQVEQQE VELPSIEGLI FINIPSWGSG ADLWGSDSDS RFEKPRIDDG
     LLEVVGVTGV VHMGQVQGGL RSGIRIAQGS YFRVTLLKAT PVQVDGEPWI QAPGHMIISA
     TAPKVHMLRK AKQKPRKAGA IRDTRVDTLP APEGNPL
//
